Status: Enrolling
Investigator: Andrew Farach
Study Coordinator: Jaya Kamath
Phone: 713.441.6616
This phase III trial compares whether the addition of pembrolizumab to radiation therapy is more effective than radiation therapy alone in reducing the risk of cancer coming back (recurrence) in patients with newly diagnosed stage I-II endometri ... Read more >